Cancer

News

Transgene begins trials of head and neck cancer vaccine

Virus-based immunotherapy biotech Transgene is to begin clinical trials of its head and neck cancer drug candidate TG4050 after gaining regulatory clearance from the UK regulator.<

Views & Analysis

Can in vivo imaging deliver the full potential of immunother...

In the quest to control cancer we now face the challenge of translating our increasing insights into the cancer-immunity cycle into more effective immune therapies.

Views & Analysis

Harnessing investment and entrepreneurship to fight cancer

As cancer treatments evolve, so must investment mechanisms

Last month’s American Society of Clinical Oncology (ASCO) meeting kicked off with a presentation from Professor Ruth Plummer, a medical oncologist from Newcastle in the UK who, in 2003, was

News

Immediately after EU nod, England's NHS funds Sanofi skin ca...

Patients in England will be among those who are first to benefit from Sanofi and Regeneron’s new cancer immunotherapy Libtayo, after NICE recommended funding for a form of skin cancer immed

News

Janssen J&J Johnson and Johnson pharmaceutical companies

FDA quickly approves J&J's Darzalex in multiple myeloma

Johnson & Johnson’s Darzalex has acquired another indication after the FDA quickly approved it as part of a combination in newly-diagnosed multiple myeloma patients who are transplant i

News

Denmark's Genmab prepares for $500m US IPO

Antibody-based drugs firm Genmab, noted for developing the blood cancer drug Darzalex with Johnson & Johnson’s Janssen unit, is preparing for a $500 million US IPO.

Transgene begins trials of head and neck cancer vaccine

Can in vivo imaging deliver the full potential of immunother...

As cancer treatments evolve, so must investment mechanisms

Immediately after EU nod, England's NHS funds Sanofi skin ca...

FDA quickly approves J&J's Darzalex in multiple myeloma

Denmark's Genmab prepares for $500m US IPO

Roche, Viking, and Syntis showcase obesity drug candidates

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks